meta-analysis | Q815382 |
scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Angus W MacDonald | Q48559165 |
P2093 | author name string | Cameron S Carter | |
Beth E Snitz | |||
P2860 | cites work | The endophenotype concept in psychiatry: etymology and strategic intentions | Q28187744 |
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis | Q28287123 | ||
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia | Q29614929 | ||
Misunderstanding analysis of covariance | Q33181804 | ||
Problems in the measurement of cognitive deficit | Q69527966 | ||
Analysis of the attention deficit in schizophrenia: A study of patients and their relatives in Ireland | Q71943664 | ||
Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers | Q72088105 | ||
Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings | Q73298790 | ||
Antisaccade performance in biological relatives of schizophrenia patients: a meta-analysis | Q80578994 | ||
Antisaccade performance is impaired in medically and psychiatrically healthy biological relatives of schizophrenia patients | Q80579006 | ||
A meta-analysis of the neuropsychological sequelae of HIV infection | Q34522272 | ||
Cognitive experimental approaches to investigating impaired cognition in schizophrenia: a paradigm shift. | Q35089016 | ||
Genetic evidence for cognitive reserve: variations in memory and related cognitive functions. | Q35158032 | ||
A quantitative review of the effects of traumatic brain injury on cognitive functioning | Q35847225 | ||
Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis | Q38414048 | ||
Language comprehension in schizophrenics and their brothers | Q38471860 | ||
Neuropsychological and P300 abnormalities in schizophrenics and their relatives. | Q38567068 | ||
Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? | Q40470324 | ||
Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis | Q40550422 | ||
Neuropsychological risk indicators for schizophrenia: a review of family studies. | Q40759032 | ||
The genetics of schizophrenia: a current, genetic-epidemiologic perspective | Q40821125 | ||
Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration | Q41097850 | ||
Neuropsychological indicators of the vulnerability to schizophrenia | Q41107896 | ||
Familial prevalence and coaggregation of schizotypy indicators: a multitrait family study | Q41186497 | ||
Of apples and oranges, file drawers and garbage: why validity issues in meta-analysis will not go away | Q41687608 | ||
Saccadic eye movement abnormalities in relatives of patients with schizophrenia | Q43466442 | ||
Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia | Q44241333 | ||
Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study | Q44390647 | ||
Schizotypal symptoms and signs in the Roscommon Family Study. Their factor structure and familial relationship with psychotic and affective disorders | Q44540866 | ||
Self-report measures of schizotypy as indices of familial vulnerability to schizophrenia | Q45100481 | ||
Neuropsychological risk indicators for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probands. | Q45947962 | ||
Genetic influences on frontal brain function: WCST performance in twins | Q48170495 | ||
Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia | Q48186308 | ||
Perceptual aberrations, schizotypy, and the Wisconsin Card Sorting Test | Q48210860 | ||
Cognitive functioning and anhedonia in subjects at risk for schizophrenia | Q48273531 | ||
A modified card sorting test sensitive to frontal lobe defects | Q48346552 | ||
Antisaccades and smooth pursuit eye tracking and schizotypy | Q48396353 | ||
A specific deficit in context processing in the unaffected siblings of patients with schizophrenia. | Q48413938 | ||
Saccadic disinhibition in patients with acute and remitted schizophrenia and their first-degree biological relatives. | Q49120369 | ||
Spatial working memory deficits in the relatives of schizophrenic patients. | Q49132201 | ||
Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. | Q50866944 | ||
Spatial, object, and affective working memory in social anhedonia: an exploratory study. | Q51018708 | ||
Neurocognitive correlates of schizotypy in first degree relatives of schizophrenia patients. | Q51028463 | ||
A continuous performance test of brain damage. | Q51329872 | ||
Antisaccade performance is abnormal in schizophrenia patients but not in their biological relatives. | Q51947463 | ||
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. | Q51956741 | ||
Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. | Q51975653 | ||
Cognitive dysfunctions in parents of schizophrenic patients parallel the deficits found in patients. | Q52005757 | ||
A meta-analysis for neurobehavioural results due to occupational mercury exposure. | Q52013274 | ||
Auditory working memory and verbal recall memory in schizotypy. | Q52027995 | ||
Association of neuropsychological vulnerability markers in relatives of schizophrenic patients. | Q52038294 | ||
Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. | Q52038454 | ||
Selection of controls for family studies. Biases and implications. | Q52068667 | ||
Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. | Q52178971 | ||
The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients. | Q52245742 | ||
The '3 Rs' and neuropsychological function in schizophrenia: a test of the matching fallacy in biological relatives. | Q52346854 | ||
Genetics of human prefrontal function | Q60628072 | ||
No deficit in Wisconsin Card Sorting Test performance of schizophrenic patients' first-degree relatives | Q60646658 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
meta-analysis | Q815382 | ||
endophenotype | Q2032061 | ||
P304 | page(s) | 179-194 | |
P577 | publication date | 2005-09-15 | |
P1433 | published in | Schizophrenia Bulletin | Q4049133 |
P1476 | title | Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes | |
P478 | volume | 32 |
Q34539874 | A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes |
Q37076840 | A cross-sectional analysis of the development of response inhibition in children with chromosome 22q11.2 deletion syndrome |
Q38873400 | A feasibility study of a new computerised cognitive remediation for young adults with schizophrenia |
Q27324628 | A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment |
Q35223786 | A multivariate perspective on schizotypy and familial association with schizophrenia: a review |
Q38181468 | A neurobiological approach to the cognitive deficits of psychiatric disorders |
Q38603544 | A polygenic risk score analysis of psychosis endophenotypes across brain functional, structural, and cognitive domains |
Q44388729 | A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis |
Q37131062 | A randomized trial comparing in person and electronic interventions for improving adherence to oral medications in schizophrenia |
Q48638124 | A resting-state functional magnetic resonance imaging study on the first-degree relatives of persons with schizophrenia. |
Q36721400 | A systematic review and meta-analysis of set-shifting ability in eating disorders |
Q97643125 | A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits |
Q28596920 | A watershed model of individual differences in fluid intelligence |
Q90252559 | Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task |
Q30494518 | Advances in endophenotyping schizophrenia |
Q38751448 | An Indian experience of neurocognitive endophenotypic markers in unaffected first-degree relatives of schizophrenia patients |
Q33772253 | An automated method to analyze language use in patients with schizophrenia and their first-degree relatives |
Q37127670 | Anterior Cingulate Cortico-Hippocampal Dysconnectivity in Unaffected Relatives of Schizophrenia Patients: A Stochastic Dynamic Causal Modeling Study |
Q30476366 | Are auditory-evoked frequency and duration mismatch negativity deficits endophenotypic for schizophrenia? High-density electrical mapping in clinically unaffected first-degree relatives and first-episode and chronic schizophrenia |
Q31120592 | Are brain structural abnormalities useful as endophenotypes in schizophrenia? |
Q27027555 | Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics |
Q47595201 | Assessment of Cognition and Personality as Potential Endophenotypes in the Western Australian Family Study of Schizophrenia |
Q28732827 | Association analysis of 94 candidate genes and schizophrenia-related endophenotypes |
Q37650376 | Association between polygenic risk for schizophrenia, neurocognition and social cognition across development. |
Q36409056 | Association of a Serotonin Receptor 2A Gene Polymorphism with Visual Sustained Attention in Early-Onset Schizophrenia Patients and their Non-Psychotic Siblings |
Q37404810 | Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis |
Q49095156 | Association of genetic variations in DTNBP1 with cognitive function in schizophrenia patients and healthy subjects. |
Q33692336 | Association study of neuregulin-1 gene polymorphisms in a North Indian schizophrenia sample |
Q47583502 | Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. |
Q44778120 | Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics |
Q89863897 | Associations of psychotic-like experiences, related symptoms, and working memory with functioning |
Q35243704 | Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS). |
Q47863961 | Auditory Vigilance and Working Memory in Youth at Familial Risk for Schizophrenia or Affective Psychosis in the Harvard Adolescent Family High Risk Study |
Q31112799 | Auditory verbal hallucinations: neuroimaging and treatment. |
Q30455072 | Auditory working memory impairments in individuals at familial high risk for schizophrenia |
Q28277283 | Autism As a Disorder of High Intelligence |
Q33926119 | Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study |
Q48319075 | Beneficial effects of electrostimulation contingencies on sustained attention and electrocortical activity |
Q38170141 | Biomarkers in psychosis: an approach to early identification and individualized treatment. |
Q36320593 | Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects |
Q37228341 | Brain circuits that link schizophrenia to high risk of cigarette smoking |
Q37346822 | CNTRICS final task selection: control of attention |
Q24651882 | CNTRICS final task selection: executive control |
Q29308426 | CNVs conferring risk of autism or schizophrenia affect cognition in controls |
Q37461063 | Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour? |
Q31095554 | Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? |
Q50993509 | Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. |
Q33690407 | Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach |
Q36180283 | Central Coherence in Eating Disorders: A Synthesis of Studies Using the Rey Osterrieth Complex Figure Test |
Q35744870 | Cerebral Inefficient Activation in Schizophrenia Patients and Their Unaffected Parents during the N-Back Working Memory Task: A Family fMRI Study |
Q92778880 | Childhood trauma and cognitive functioning in individuals at clinical high risk (CHR) for psychosis |
Q41756731 | Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype |
Q46308560 | Clinical neuropsychology within adolescent and young-adult psychiatry: conceptualizing theory and practice |
Q52606962 | Clustering of Schizotypal Features in Unaffected First-Degree Relatives of Schizophrenia Patients. |
Q50954527 | Cognition and Social Cognition in non-psychotic siblings of patients with schizophrenia. |
Q31033638 | Cognition and resting-state functional connectivity in schizophrenia |
Q33707698 | Cognition in mouse models of schizophrenia susceptibility genes |
Q37387648 | Cognition in schizophrenia: core psychological and neural mechanisms |
Q34699360 | Cognition, dopamine and bioactive lipids in schizophrenia |
Q44741809 | Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents |
Q30476447 | Cognitive control deficits in schizophrenia: mechanisms and meaning |
Q64121441 | Cognitive correlates of abnormal myelination in psychosis |
Q38194586 | Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. |
Q60307712 | Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families |
Q26771515 | Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses |
Q35957514 | Cognitive endophenotypes of psychosis within dimension and diagnosis |
Q35390206 | Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls |
Q38371484 | Cognitive functioning in schizotypy through the lens of the accessibility model. |
Q104795222 | Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings |
Q95586193 | Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations |
Q43499240 | Cognitive profiles of healthy siblings of schizophrenia patients: application of the cognitive domains of the MATRICS consensus battery |
Q46821456 | Common and disease-specific dysfunctions of brain systems underlying attentional and executive control in schizophrenia and bipolar disorder |
Q36572060 | Communication disturbances, working memory, and emotion in people with elevated disorganized schizotypy |
Q30474963 | Contribution of nonprimate animal models in understanding the etiology of schizophrenia |
Q36307544 | Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments |
Q36882250 | Counterfactual Reasoning in Non-psychotic First-Degree Relatives of People with Schizophrenia. |
Q38642835 | Cross-Disorder Cognitive Impairments in Youth Referred for Neuropsychiatric Evaluation |
Q26745793 | Current understandings about cognition and the neurobiological correlates in schizophrenia |
Q33678248 | Data-driven methodology illustrating mechanisms underlying word list recall: applications to clinical research |
Q36646593 | Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder |
Q89471379 | Defining cognitive and functional profiles in schizophrenia and affective disorders |
Q41868067 | Developing a Cognitive Training Strategy for First-Episode Schizophrenia: Integrating Bottom-Up and Top-Down Approaches |
Q38153346 | Development of liability syndromes for schizophrenia: where did they come from and where are they going? |
Q34863670 | Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort |
Q34162964 | Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals |
Q28081581 | Diffusion tensor imaging in first degree relatives of schizophrenia and bipolar disorder patients |
Q34663828 | Discovering schizophrenia endophenotypes in randomly ascertained pedigrees |
Q34443241 | Discrimination within Recognition Memory in Schizophrenia. |
Q37393835 | Dissecting psychiatric spectrum disorders by generative embedding |
Q51869763 | Dissociable and common deficits in inhibitory control in schizophrenia and bipolar disorder. |
Q37411471 | Dysconnectivity in the frontoparietal attention network in schizophrenia |
Q48025820 | Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis |
Q35136571 | Early sensory contributions to contextual encoding deficits in schizophrenia |
Q44490894 | Effects of a CACNA1C genotype on attention networks in healthy individuals |
Q48659041 | Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia. |
Q57310577 | Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls |
Q47773103 | Effort-cost decision-making in psychosis and depression: could a similar behavioral deficit arise from disparate psychological and neural mechanisms? |
Q34048579 | Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories |
Q50803618 | Emotion perception and learning potential: mediators between neurocognition and social problem-solving in schizophrenia? |
Q30487300 | Emotion processing in persons at risk for schizophrenia |
Q38065248 | Emotional memory modulation in schizophrenia: an overview |
Q64100728 | Enhanced Global-Brain Functional Connectivity in the Left Superior Frontal Gyrus as a Possible Endophenotype for Schizophrenia |
Q55256851 | Enhanced switching and familial susceptibility for psychosis. |
Q38079160 | Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors |
Q53349063 | Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. |
Q39412337 | Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms |
Q37945156 | Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. |
Q48314987 | Evidence that hippocampal-parahippocampal dysfunction is related to genetic risk for schizophrenia |
Q35680056 | Examining the Psychosis Continuum |
Q44047002 | Executive dysfunction in Turkish children at high risk for schizophrenia |
Q50716056 | Executive functioning and psychopathological profile in relatives of individuals with deficit v. non-deficit schizophrenia: a pilot study. |
Q39517216 | Executive functioning in individuals with schizophrenia and/or cocaine dependence. |
Q85188206 | Executive functioning-related brain abnormalities associated with the genetic liability for schizophrenia: an activation likelihood estimation meta-analysis |
Q33773726 | Expression of DISC1-interactome members correlates with cognitive phenotypes related to schizophrenia |
Q36304346 | Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. |
Q50744155 | Facial affect recognition deficit as a marker of genetic vulnerability to schizophrenia. |
Q37075916 | Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia |
Q37623349 | Failure to benefit from target novelty during encoding contributes to working memory deficits in schizophrenia |
Q46162601 | Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives. |
Q33619294 | Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia |
Q37256249 | Familiarity and recollection processes in patients with recent-onset schizophrenia and their unaffected parents |
Q36032824 | Functional neuroanatomical correlates of episodic memory impairment in early phase psychosis |
Q33587959 | General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance |
Q36510741 | Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis |
Q51924211 | Genetic architecture of verbal abilities in children and adolescents. |
Q35791049 | Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families |
Q97905480 | Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study |
Q34638217 | Genetic epidemiology, endophenotypes, and eating disorder classification |
Q38697005 | Genetics of cognitive control: Implications for Nimh's research domain criteria initiative |
Q36821227 | Getting beneath the phenotype of anorexia nervosa: the search for viable endophenotypes and genotypes |
Q64887855 | Global and Specific Profiles of Executive Functioning in Prodromal and Early Psychosis. |
Q44412213 | Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). |
Q39016071 | Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis |
Q83739091 | Heritability of Trail Making Test performance in multiplex schizophrenia families: implications for the search for an endophenotype |
Q35089433 | Heritability of neurocognitive traits in familial schizophrenia |
Q98305991 | Heritability of specific cognitive functions and associations with schizophrenia spectrum disorders using CANTAB: a nation-wide twin study |
Q35019621 | Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability |
Q35213673 | How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library |
Q24642111 | Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia |
Q87382641 | INECO frontal screening: an instrument to assess executive dysfunction in schizophrenia |
Q31159319 | Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients' nonpsychotic relatives |
Q35234966 | Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. |
Q34497578 | Impaired Set-Shifting Ability in Patients with Eating Disorders, Which Is Not Moderated by Their Catechol-O-Methyltransferase Val158Met Genotype |
Q48594983 | Increased inferior frontal activation during word generation: a marker of genetic risk for schizophrenia but not bipolar disorder? |
Q46815103 | Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia |
Q36940031 | Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition |
Q38674187 | Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis |
Q46119024 | Introduction to Special Theme Issue. |
Q45919191 | Introduction: genes, cognition and neuropsychiatry. |
Q47695968 | Is Emotional Intelligence Impaired in Unaffected Siblings of Patients with Schizophrenia? |
Q53432876 | Is inefficient cognitive processing in anorexia nervosa a familial trait? A neuropsychological pilot study of mothers of offspring with a diagnosis of anorexia nervosa. |
Q36887049 | Life Course Challenges Faced by Siblings of Individuals with Schizophrenia May Increase Risk for Depressive Symptoms |
Q57152586 | Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings |
Q92425476 | Machine learning identifies unaffected first-degree relatives with functional network patterns and cognitive impairment similar to those of schizophrenia patients |
Q36460580 | Measuring Attention in Rodents: Comparison of a Modified Signal Detection Task and the 5-Choice Serial Reaction Time Task |
Q36113741 | Memory systems in schizophrenia: Modularity is preserved but deficits are generalized. |
Q36964951 | Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. |
Q34023290 | Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis |
Q36768430 | Monkey Prefrontal Neurons Reflect Logical Operations for Cognitive Control in a Variant of the AX Continuous Performance Task (AX-CPT). |
Q39931392 | Network Profiles of the Dorsal Anterior Cingulate and Dorsal Prefrontal Cortex in Schizophrenia During Hippocampal-Based Associative Memory |
Q36690643 | Neural Dysfunction in Cognitive Control Circuits in Persons at Clinical High-Risk for Psychosis |
Q89747537 | Neuregulin 3 rs10748842 polymorphism contributes to the effect of body mass index on cognitive impairment in patients with schizophrenia |
Q91637851 | Neuroactive Steroids and Cognitive Functions in First-Episode Psychosis Patients and Their Healthy Siblings |
Q90668520 | Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia |
Q36625363 | Neurocognition in youth and young adults under age 30 at familial risk for schizophrenia: a quantitative and qualitative review |
Q59047727 | Neurocognitive Basis of Schizophrenia: Information Processing Abnormalities and Clues for Treatment |
Q33771987 | Neurocognitive Impairments in Unaffected First-degree Relatives of Schizophrenia. |
Q94452844 | Neurocognitive Profile in Indian Individuals Genetically at Risk of Schizophrenia |
Q30488649 | Neurocognitive allied phenotypes for schizophrenia and bipolar disorder |
Q36072702 | Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia |
Q35637422 | Neurocognitive performance in family-based and case-control studies of schizophrenia |
Q37130977 | Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia |
Q51053046 | Neurocognitive prediction of illness knowledge after psychoeducation in schizophrenia: results from the Munich COGPIP study. |
Q35176762 | Neurocognitive predictors of work outcome in recent-onset schizophrenia |
Q51862226 | Neurodevelopmental factors associated with schizotypal symptoms among adolescents at risk for schizophrenia. |
Q37563553 | Neuropsychological abnormalities in schizophrenia and major mood disorders: similarities and differences |
Q37075894 | Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies |
Q56992231 | Neuropsychological impairments predict the clinical course in schizophrenia |
Q35903811 | Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis |
Q30543180 | Nonverbal delayed recognition in the relatives of schizophrenia patients with or without schizophrenia spectrum |
Q51813550 | Not All Differences between Patients with Schizophrenia and Healthy Subjects Are Pathological: Performance on the Conners' Continuous Performance Test. |
Q51024060 | Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients. |
Q37581121 | Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis |
Q24289198 | Oligodendrocyte genes, white matter tract integrity, and cognition in schizophrenia |
Q42254803 | P300 and neuropsychological measurements in patients with schizophrenia and their healthy biological siblings |
Q33762473 | Parental communication and psychosis: a meta-analysis. |
Q89581110 | Parvalbumin Interneuron Dysfunction in a Thalamo-Prefrontal Cortical Circuit in Disc1 Locus Impairment Mice |
Q37223804 | Performance of Verbal Fluency as an Endophenotype in Patients with Familial versus Sporadic Schizophrenia and Their Parents |
Q36770098 | Performance on the Wisconsin Card Sorting Test in families of schizophrenia patients with different familial loadings |
Q34726454 | Personalized medicine in psychiatry: problems and promises |
Q92368876 | Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways |
Q39289466 | Predicting Cognitive Executive Functioning with Polygenic Risk Scores for Psychiatric Disorders. |
Q37699372 | Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction |
Q33731772 | Premorbid cognitive deficits in young relatives of schizophrenia patients |
Q36846481 | Preserved Intention Maintenance and Impaired Execution of Prospective Memory Responses in Schizophrenia: Evidence from an Event-based Prospective Memory Study |
Q37768447 | Prevention of schizophrenia |
Q35189908 | Procedural learning impairments identified via predictive saccades in chronic traumatic brain injury |
Q30407411 | Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients |
Q38187948 | Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets |
Q99238113 | Psychosis and Psychotic-Like Symptoms Affect Cognitive Abilities but Not Motivation in a Foraging Task |
Q28551625 | Psychotic Experiences and Working Memory: A Population-Based Study Using Signal-Detection Analysis |
Q46795996 | Putative role of the COMT gene polymorphism (Val158Met) on verbal working memory functioning in a healthy population. |
Q24622263 | RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample |
Q44600736 | Refining the latent structure of neuropsychological performance in schizophrenia |
Q48484122 | Regional white matter abnormalities in drug-naive, first-episode schizophrenia patients and their healthy unaffected siblings. |
Q34088104 | Relationship between prefrontal gray matter volumes and working memory performance in schizophrenia: a family study |
Q36936347 | Schizophrenia endophenotypes as treatment targets |
Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
Q37461052 | Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers |
Q35768211 | Schizophrenic patients and their unaffected siblings share increased resting-state connectivity in the task-negative network but not its anticorrelated task-positive network. |
Q35037650 | Self-reported affective traits and current affective experiences of biological relatives of people with schizophrenia |
Q33986685 | Serum glutamine, set-shifting ability and anorexia nervosa |
Q36303145 | Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? |
Q37637086 | Sex differences in familiality effects on neurocognitive performance in schizophrenia |
Q35579207 | Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder |
Q37310194 | Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern quebec multigenerational families |
Q47550304 | Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis. |
Q37426505 | Sleep and plasticity in schizophrenia |
Q41523007 | Smaller than expected cognitive deficits in schizophrenia patients from the population-representative ABC catchment cohort |
Q34235369 | Social cognition deficits among individuals at familial high risk for schizophrenia |
Q37021707 | Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? |
Q37210519 | Social motor coordination in unaffected relatives of schizophrenia patients: a potential intermediate phenotype |
Q34023184 | Spatial working memory ability in individuals at ultra high risk for psychosis |
Q51958200 | Specific cognitive deficits in a group at genetic high risk of schizophrenia. |
Q43569782 | Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability? |
Q24643863 | Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? |
Q94551179 | Subjective cognitive complaints and its relation to objective cognitive performance, clinical profile, clinical insight, and social functioning in patients of schizophrenia: A cross-sectional study |
Q34370486 | Substantial SNP-based heritability estimates for working memory performance |
Q52893167 | Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients. |
Q58800608 | Superior memory performance in healthy individuals with subclinical psychotic symptoms but without genetic load for schizophrenia |
Q46844492 | Sustained attention and working memory deficits follow a familial pattern in schizophrenia. |
Q38767226 | Symptomatic Remission and Counterfactual Reasoning in Schizophrenia |
Q37137008 | Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem |
Q24654023 | Temperament and character as schizophrenia-related endophenotypes in non-psychotic siblings |
Q34279073 | The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions |
Q48794168 | The AKT1 gene is associated with attention and brain morphology in schizophrenia. |
Q59052397 | The Concept of Schizophrenia: From Unity to Diversity |
Q36652587 | The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes |
Q48887019 | The KCNH2 gene is associated with neurocognition and the risk of schizophrenia. |
Q37568528 | The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology |
Q33730345 | The development of cognitive control in children with chromosome 22q11.2 deletion syndrome |
Q33695382 | The effect of COMT Val158Met and DRD2 C957T polymorphisms on executive function and the impact of early life stress |
Q34344448 | The effect of odor valence on olfactory performance in schizophrenia patients, unaffected relatives and at-risk youth |
Q37678438 | The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review. |
Q34173810 | The effects of a DTNBP1 gene variant on attention networks: an fMRI study |
Q38077155 | The evolutionary paradox and the missing heritability of schizophrenia |
Q92965063 | The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders |
Q45791025 | The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. |
Q48513096 | The impact of dystrobrevin-binding protein 1 (DTNBP1) on neural correlates of episodic memory encoding and retrieval. |
Q35596936 | The impact of parent socio-economic status on executive functioning and cortical morphology in individuals with schizophrenia and healthy controls |
Q31120588 | The neurobiological underpinnings of risk and conversion in relatives of patients with schizophrenia |
Q37606626 | The psychoses: cluster 3 of the proposed meta-structure for DSM-V and ICD-11. |
Q34660603 | The relationship between obesity and neurocognitive function in Chinese patients with schizophrenia |
Q37182912 | The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis |
Q51957715 | The role of cannabis in cognitive functioning of patients with schizophrenia. |
Q33769050 | The shine-through masking paradigm is a potential endophenotype of schizophrenia |
Q37076190 | The stability of inhibitory and working memory deficits in children and adolescents who are children of parents with schizophrenia |
Q37813206 | The treatment of cognitive impairment in schizophrenia |
Q48766822 | Theory of Mind as a potential trait marker of schizophrenia: a family study. |
Q47916430 | Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls |
Q35759100 | Three dysconnectivity patterns in treatment-resistant schizophrenia patients and their unaffected siblings |
Q39478402 | Touchscreen-paradigm for mice reveals cross-species evidence for an antagonistic relationship of cognitive flexibility and stability |
Q38934872 | Transdiagnostic impairment of cognitive control in mental illness |
Q37580487 | Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives. |
Q88868364 | Variability of ecological executive function in children and adolescents genetically at high risk for schizophrenia: a latent class analysis |
Q35390594 | Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories |
Q36609585 | Verbal and visual-spatial memory impairment in youth at familial risk for schizophrenia or affective psychosis: a pilot study |
Q36862072 | Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia |
Q50531595 | Visual working memory encoding in schizophrenia and first-degree relatives: neurofunctional abnormalities and impaired consolidation. |
Q38270192 | WORKING MEMORY IMPAIRMENT AS AN ENDOPHENOTYPIC MARKER OF A SCHIZOPHRENIA DIATHESIS. |
Q37159625 | What we know: findings that every theory of schizophrenia should explain. |
Q36386310 | White matter development in adolescence: diffusion tensor imaging and meta-analytic results |
Q36517980 | White matter organization and neurocognitive performance variability in schizophrenia |
Q37588171 | Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment |
Q34164672 | Working memory encoding and false memory in schizophrenia and bipolar disorder in a spatial delayed response task |
Q27014678 | Working memory training in schizophrenia and healthy populations |
Q33895141 | Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time |
Q52001214 | [Relevance of cognitive tools for early diagnosis of schizophrenia]. |
Q85823847 | [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes] |
Search more.